MAYNF MAYNE PHARMA GROUP LIMITED
- 4.480000
- 0.0000000.00%
MAYNE PHARMA GROUP LIMITED News
Mayne Pharma Group Limited's (ASX:MYX) Largest Shareholders Are Individual Investors With 38% Ownership, Institutions Own 33%
Analysts Expect Breakeven For Mayne Pharma Group Limited (ASX:MYX) Before Long
Earnings Call Summary | MAYNE PHARMA GROUP LIMITED(MAYNF.US) Q2 2024 Earnings Conference
The following is a summary of the Mayne Pharma Group Limited (MAYNF) Q2 2024 Earnings Call Transcript:Financial Performance:Mayne Pharma reported a gross profit of $105.8 million, reflecting a margin
Retail Investors Account for 50% of Mayne Pharma Group Limited's (ASX:MYX) Ownership, While Institutions Account for 19%
Patrick Blake Buys 3,097 Shares of Mayne Pharma Group Limited (ASX:MYX) Stock
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Patrick Blake bought 3,097 shares of the firm's stock in a transaction on Thursday, April 13th. The stock was acquired at an average cost of A
There's No Escaping Mayne Pharma Group Limited's (ASX:MYX) Muted Revenues
Frank Condella Is The Independent Non-Executive Chairman of Mayne Pharma Group Limited (ASX:MYX) And They Just Picked Up 56% More Shares
Mayne Pharma Group Limited (ASX:MYX) Insider Acquires A$11,289.57 in Stock
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Frank Condella purchased 3,210 shares of the company's stock in a transaction dated Monday, March 27th. The stock was purchased at an average
Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Decreases By 87.5%
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling
Mayne Pharma Group Limited (ASX:MYX) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dr. Reddy's Seeks Gaining Foothold In Women's Health Via Mayne Pharma's U.S. Prescription Generic Deal
Dr. Reddy's Laboratories Ltd (NYSE:RDY) has agreed to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Limited (OTC:MAYND) (OTC:MAYNF) (OTC:MYPHY). Under t
Dr. Reddy's to Acquire U.S. Generic Portfolio of Mayne Pharma
Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Expands By 2,081.6%
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totallin
MAYNE PHARMA GROUP LIMITED will be removed from power and interest on January 18, 2023, and 20 shares will be merged into 1 share
On January 17, it was reported that $MAYNE PHARMA GROUP LIMITED (MAYNF.US) $ will be deducted from interest on January 18, 2023, and 20 shares will be merged into 1 share. By the close of January 13, $MAYNE PHARMA GROUP LIMITED (MAYNF.US) $ was reported at $0.15205, down 9.66%, with a turnover of $388.08 and a market capitalization of US$265 million. What is joint stock? A joint stock is the opposite process of stock splitting, when the stock price is
Mayne Pharma Group Limited (OTCMKTS:MAYNF) Short Interest Up 88.9% in December
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 62
Mayne Pharma Group Limited (ASX:MYX) Most Popular Amongst Individual Investors Who Own 56% of the Shares, Institutions Hold 20%
Analysts' Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH) and Mayne Pharma Group Limited (OtherMAYNF)
Canaccord Genuity Sticks to Their Buy Rating for Mayne Pharma Group Limited (MAYNF)
Mayne Pharma Group Limited (ASX:MYX) Analysts Just Trimmed Their Revenue Forecasts By 19%
Mayne Pharma Group Limited (OTCMKTS:MAYNF) Sees Large Decline in Short Interest
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest tota
Analysis
Price Target
No Data
